“…Therefore, inhibition of human DNMT is an effective strategy for treating various cancers (Ehrlich, 2002;Esteller 2002;Gilbert et al, 2004;Herman & Baylin, 2003). Base-modified nucleoside analogues, such as 5-aza-2 -deoxycytidine (d N C) (Christman, 2002;Kuch, Schermelleh, Manetto, Leonhardt, & Carell, 2008;Momparler, Momparler, & Samson, 1984) and 5fluoro-2 -deoxycytidine (d F C) (Chen et al, 1991;Osterman, DePillis, Wu, Matsuda, & Santi, 1988), act as suicide inhibitors of DN-MTs after incorporation into genomic DNA at CpG sites. In DNA, the modified-nucleobase forms a covalent bond with the Cys residue (Klimašauskas, Kumar, Roberts, & Cheng, 1994;Santi, Norment, & Garrett, 1984;Zhou et al, 2002).…”